CAS: 1000995-47-0

Chloramultilide B is a complex macrolide, which is a type of natural product characterized by a large macrocyclic lactone ring. It is derived from marine bacteria, specifically isolated from Streptomyces species known for their prolific production of bioactive secondary metabolites. The mode of action of Chloramultilide B involves targeting and disrupting bacterial cell wall synthesis. This is achieved through its interaction with specific bacterial enzymes, leading to the inhibition of cell growth and ultimately resulting in bacterial cell death. Chloramultilide B has shown promise in various applications due to its antibacterial properties, particularly against resistant strains of bacteria. Its unique structural framework also makes it a subject of interest for synthetic modification and the development of novel analogs. Research on Chloramultilide B focuses on its potential integration into new antibiotic therapies aimed at combating resistant pathogens, thus addressing a critical need in modern medicine. Its study not only contributes to our understanding of marine-derived natural products but also enhances the strategic development of new antimicrobial agents.

Chloramultilide B exhibits moderate in vitro antifungal activity.